Andrew G.Jack (Drew)

Partner

Columbus + 1.614.281.3679

Connect:

Share

Drew Jack is a health care and life sciences transactional and regulatory lawyer with significant experience in health care M&A and affiliation transactions, cutting-edge integration and alignment strategies, life sciences and clinical research matters, and value-based care models.

Drew's experience includes guiding clients through strategic transactions, including hospital M&A transactions, affiliations, joint ventures, service line revenue mergers, and clinical laboratory acquisitions and management arrangements; developing hospital-physician alignment strategies, including co-management, gainsharing, and hospital quality and efficiency programs; working with health care providers to develop clinically integrated provider networks and accountable care organizations; and counseling clients on health care fraud and abuse issues, including compliance with the Stark Law, Anti-Kickback Statute, and Civil Monetary Penalties Law and use of applicable fraud and abuse waivers. Drew has also worked with clients in the life sciences industry in connection with multijurisdictional clinical trials and research collaborations.

Drew is a member of the American Health Law Association. He also is a member of the Columbus Office's Hiring Committee and Diversity, Inclusion & Advancement Committee and serves as the Mentoring Program coordinator for the Columbus Office.

Experience

  • Ascension enters into strategic laboratory collaboration with LabcorpJones Day advised Ascension with respect to its strategic alliance with Labcorp whereby Labcorp will manage Ascension’s hospital-based laboratories in 10 states and purchase the assets of the health system’s outreach laboratory business.
  • Health system utilizes value-based regulations to offer EHR and related digital health solutions to providersJones Day assisted a leading health system in the southern U.S. in offering innovative EHR and related digital health solutions to independent providers via the value-based exceptions and safe harbors.
  • Private equity-backed post-acute care organization forms CINJones Day assisted a for-profit, private equity-backed company in creating an innovative post-acute care clinically integrated network in the southwestern U.S.
  • Home care provider organization forms CIN, Messenger ModelJones Day assisted a Southeast-based private for-profit home care provider in forming a clinically integrated network and a messenger model.
  • VUMC acquires Tennova Shelbyville and Tullahoma Hospitals from Community Health Systems, Inc., and acquire minority interest in Tennova Clarksville HospitalJones Day advised Vanderbilt University Medical Center (VUMC) in its acquisition of substantially all of the assets of Tennova Healthcare-Shelbyville, a 60-bed hospital located in Shelbyville, Tennessee, and Tennova Healthcare-Harton, a 135-bed hospital located in Tullahoma, Tennessee, from subsidiaries of Community Health Systems.
  • Methodist Health acquired by Deaconess Health SystemJones Day advised Methodist Health in Kentucky in its acquisition by Deaconess Health System, which included two hospitals, as well as associated physicians and post-acute care providers.
  • Integrated Medical Professionals sold to Lee Equity PartnersJones Day advised Integrated Medical Professionals, PLLC, a multi-specialty physician group specializing in urology, radiation oncology, and pathology, in its acquisition by Lee Equity Partners.
  • Telemedicine provider expands telehealth programming in response to COVID-19 public health crisisJones Day represented a telemedicine provider in their expansion of telehealth programming in response to the COVID-19 public health crisis.
  • Sumitomo Dainippon Pharma acquires late stage biopharma companies and forms alliance with Roivant Sciences Ltd. worth $3 billionJones Day advised Sumitomo Dainippon Pharma Co., Ltd. ("Sumitomo") in an acquisition of late stage biopharma companies and formation of alliance with Roivant Sciences Ltd.
  • AKSM receives $550,000 investmentJones Day represented AKSM Ltd., a Columbus-based medical company, in connection with a $550,000 investment from undisclosed investors.
  • AKSM involved in joint ventures with urologists regarding lithotripsy, radiation therapy, and related urologic proceduresJones Day has been assisting American Kidney Stone Management, Ltd. ("AKSM"), a leading national lithotripsy provider, with joint venture syndication work relating to lithotripsy, as well as most ancillary urology related lines of business.
  • COUG enters into ASC, radiation therapy, lithotripsy, and other urological ventures as largest single specialty urology practice in OhioJones Day assisted Central Ohio Urology Group, the largest lithotripsy supergroup in Ohio, with the formation of an IMRT/IGRT enterprise and the later sale of a majority stake in that enterprise to a third party.
  • ProMedica Health Network accepted in Medicare Shared Savings ProgramJones Day advised ProMedica Health Network, an affiliate of ProMedica Health System, in connection with its successful application for participation in the Medicare Shared Savings Program.
  • ProMedica signs Academic Affiliation Agreement with University of ToledoJones Day represented ProMedica, one of Ohio's largest health systems and a mission-based, not-for-profit healthcare organization, in negotiations with the University of Toledo and its College of Medicine & Life Sciences to develop a premier academic medical center with an emphasis on teaching, research, and the use of technology and evidence-based medicine, for the purpose of enhancing the recruitment and retention of high-quality faculty, students, residents, fellows, and allied health professionals in the region.
  • Jefferies finances AMAG Pharmaceuticals' acquisition of Cord Blood Registry®Jones Day advised Jefferies Finance LLC, as administrative agent, collateral agent, joint lead arranger and joint bookrunner, and Jefferies LLC, as representative of the initial purchasers, in connection with the $850 million in financing provided to AMAG Pharmaceuticals, Inc., a specialty pharmaceutical company with a focus on maternal health, anemia, and cancer supportive care, to finance a portion of its acquisition of Cord Blood Registry® (CBR®), a large stem cell collection and storage company.
  • Palos Community Hospital builds clinical affiliation with Loyola University Medical CenterJones Day assisted Palos Community Hospital in creating an innovative clinical affiliation with Loyola University Medical Center based in Illinois.
  • Bon Secours signs joint venture with Westchester Medical CenterJones Day advised Bon Secours Health System, Inc. ("BSHSI"), a Catholic health system sponsored by Bon Secours Ministries with multiple hospitals and facilities across six states, and its subsidiary, Bon Secours Charity Health System, Inc. ("BSCHS"), a three-hospital health system north of New York City, with respect to the sale of its controlling interest in BSCHS to, and the creation of an ongoing joint venture arrangement with, Westchester Medical Center ("WMC").
  • ProMedica Health System forms ProMedica Health Network, Inc.Jones Day advised ProMedica Health System on the formation and structuring of ProMedica Health Network Inc., an accountable care organization and clinically integrated network established for the purposes of promoting greater accountability for the quality, effectiveness and efficiency of health care delivered to communities throughout the States of Ohio and Michigan.
  • RockWood Equity Partners affiliate acquires Altimate MedicalJones Day advised an affiliate of RockWood Equity Partners LLC in connection with its acquisition and related financing of Altimate Medical, Inc., a manufacturer of sit-to-stand assistive devices used in patient rehabilitation, from Invacare Corporation, a manufacturer and distributor of innovative home and long-term care medical products.
  • Bon Secours St. Mary's Hospital accepted to participate in Medicare Bundled Payments for Care Improvement programJones Day assisted Bon Secours St. Mary's Hospital in connection with the development of a bundled payment program for lower extremity joint replacements (knee and hip revisions) and the hospital's successful application for participation in Model 2 of the Medicare Bundled Payments for Care Improvement program.
    • View All

    January 2023 Alert

    FDA Proposes IND Exemptions for Drug Studies of Foods, Supplements, or Cosmetics

    March 2022 Newsletters

    Vital Signs: Digital Health Law Update | Winter 2022

    August 2021 Newsletters

    Vital Signs: Digital Health Law Update | Summer 2021

    April 2021 Newsletters

    Vital Signs: Digital Health Law Update | Spring 2021

    January 2021 Newsletters

    Vital Signs: Digital Health Law Update | Winter 2021

    January 2021 Commentary

    OIG and CMS Modify AKS Safe Harbor and Stark Law Exception for EHR Donations

    October 2020 Newsletters

    Vital Signs: Digital Health Law Update | Fall 2020

    July 2020 Newsletters

    Vital Signs: Digital Health Law Update | Summer 2020

    April 2020 Newsletters

    Vital Signs: Digital Health Law Update | Spring 2020

    January 2020 Newsletters

    Vital Signs Digital Health Law Update
    View All

    Speaking Engagements

    • December 4, 2015
      Overview of Key Fraud and Abuse and Medicare Program Payment Waivers, PACT Population Health Collaborative (Webcast)
    • February 11, 2015
      Key Health Law Issues for Non-Healthcare Lawyers, Ohio State Bar Association (Webcast)
    • December 9, 2014
      Key Health Law Issues for Non-Healthcare Lawyers, Jones Day CLE Academy

    Before sending, please note:

    Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.